Coordinating gene expression during the cell cycle
Cell cycle-dependent gene transcription is tightly controlled by the retinoblastoma (RB): E2F
and DREAM complexes, which repress all cell cycle genes during quiescence. Cyclin …
and DREAM complexes, which repress all cell cycle genes during quiescence. Cyclin …
DREAM on: cell cycle control in development and disease
Perfectly orchestrated periodic gene expression during cell cycle progression is essential for
maintaining genome integrity and ensuring that cell proliferation can be stopped by …
maintaining genome integrity and ensuring that cell proliferation can be stopped by …
[HTML][HTML] Curcumenol triggered ferroptosis in lung cancer cells via lncRNA H19/miR-19b-3p/FTH1 axis
R Zhang, T Pan, Y Xiang, M Zhang, H Xie, Z Liang… - Bioactive materials, 2022 - Elsevier
Curcumenol, an effective ingredient of Wenyujin, has been reported that exerted its
antitumor potential in a few cancer types. However, the effect and molecular mechanism of …
antitumor potential in a few cancer types. However, the effect and molecular mechanism of …
Key genetic determinants driving esophageal squamous cell carcinoma initiation and immune evasion
Background & Aims Despite recent progress in identifying aberrant genetic and epigenetic
alterations in esophageal squamous cell carcinoma (ESCC), the mechanism of ESCC …
alterations in esophageal squamous cell carcinoma (ESCC), the mechanism of ESCC …
Clinical predictive value of naïve and memory T cells in advanced NSCLC
G Zhang, A Liu, Y Yang, Y Xia, W Li, Y Liu… - Frontiers in …, 2022 - frontiersin.org
Currently, there is no sensitive prognostic biomarker to screen out benefit patients from the
non-benefit population in advanced non-small cell lung cancer patients (aNSCLCs). The …
non-benefit population in advanced non-small cell lung cancer patients (aNSCLCs). The …
PCLAF promotes neuroblastoma G1/S cell cycle progression via the E2F1/PTTG1 axis
X Liu, Y Cai, C Cheng, Y Gu, X Hu, K Chen, Y Wu… - Cell death & …, 2022 - nature.com
PCLAF (PCNA clamp-associated factor), also known as PAF15/KIAA0101, is overexpressed
in most human cancers and is a predominant regulator of tumor progression. However, its …
in most human cancers and is a predominant regulator of tumor progression. However, its …
[HTML][HTML] Cellular senescence in non-small cell lung cancer
H Zhu, J Sun, C Zhang, P Li, C Tan, M Yang… - Frontiers in Bioscience …, 2023 - imrpress.com
Lung cancer has the highest mortality rate amongst all malignancies worldwide, and is the
second-highest incidence of cancer in women. Non-small cell lung cancer (NSCLC) is …
second-highest incidence of cancer in women. Non-small cell lung cancer (NSCLC) is …
[HTML][HTML] Cellular dormancy in cancer: mechanisms and potential targeting strategies
HY Min, HY Lee - … and Treatment: Official Journal of Korean …, 2023 - synapse.koreamed.org
Cancer is a leading cause of disease-related mortality worldwide. Drug resistance is one of
the primary reasons for the failure of anticancer therapy. There are a number of underlying …
the primary reasons for the failure of anticancer therapy. There are a number of underlying …
Identifying the EMT-related signature to stratify prognosis and evaluate the tumor microenvironment in lung adenocarcinoma
F Li, QZ Song, YF Zhang, XR Wang, LM Cao… - Frontiers in …, 2022 - frontiersin.org
Background: Epithelial-mesenchymal transition (EMT) is a critical process in tumor invasion
and metastasis. EMT has been shown to significantly influence the invasion, metastasis, and …
and metastasis. EMT has been shown to significantly influence the invasion, metastasis, and …
A structure-based designed small molecule depletes hRpn13Pru and a select group of KEN box proteins
Proteasome subunit hRpn13 is partially proteolyzed in certain cancer cell types to generate
hRpn13Pru by degradation of its UCHL5/Uch37-binding DEUBAD domain and retention of …
hRpn13Pru by degradation of its UCHL5/Uch37-binding DEUBAD domain and retention of …